Financial Data and Key Metrics Changes - The company's GMV for Q2 was $36.4 billion, with a first half GMV of $70.6 billion, reflecting a 45% year-over-year increase [15] - Q2 revenue reached a record $81.1 million, up 3% year-over-year, while first half revenue was $163.4 million, up 5% year-over-year [15] - Non-GAAP gross profit margin for 2025 was approximately 50%, down from 53% in the prior year [19] - Positive adjusted EBITDA of $2.1 million in Q2 and $3.5 million for the first half of 2025, marking the seventh consecutive quarter of positive adjusted EBITDA [21] Business Line Data and Key Metrics Changes - The two largest categories, tickets and travel, and fashion and luxury, grew 1510% year-over-year, driven by strong new business wins and upsell activity [15] - The home category saw a year-over-year decline of 74%, while the money transfer and payments category achieved approximately 90% year-over-year growth in Q2 [17] - Fashion and luxury category growth was partially offset by same-store sales pressure, particularly in high-end fashion and sneakers [16] Market Data and Key Metrics Changes - The United States market declined 11% year-over-year, primarily due to the contraction in the home category, while APAC grew approximately 40% year-over-year [18] - Other Americas (Canada and Latin America) grew approximately 16% year-over-year, and EMEA grew approximately 23% year-over-year, with strong performance in fashion and luxury, tickets and travel, and money transfer and payments [18] Company Strategy and Development Direction - The company aims to gain market share in existing categories and geographies while expanding into new verticals to diversify its merchant base [7] - A partnership with Human Security was announced to enhance fraud prevention capabilities in the evolving landscape of AI commerce [10] - The board authorized an additional $75 million share repurchase program, reflecting confidence in the company's long-term trajectory [13] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the solid first half performance and the potential for improvement in the second half, supported by a robust new business pipeline [6] - The company anticipates delivering an annual non-GAAP gross profit margin of approximately 52% for 2025, with expectations for higher margins in the second half [20] - Management highlighted the increasing complexity of fraud and the need for advanced solutions, positioning the company as a leader in the market [89] Other Important Information - The company ended Q2 with $339 million in cash, deposits, and investments, maintaining a debt-free balance sheet [22] - Quarterly free cash flows were $5.3 million, up from $4.1 million in the prior year, with an expectation of approximately $30 million of positive free cash flow for 2025 [22] Q&A Session Summary Question: Expectations for the second half of the year and same-store sales in fashion and luxury - Management is optimistic about the sales pipeline and expects win rates to be similar to historical levels, but same-store sales in fashion and luxury may be flat or down [27][30] Question: Impact of AgenTek Commerce on pipeline conversations - The evolving space of AgenTek Commerce is generating new conversations and budget opportunities as merchants seek to address AI-related challenges [32][34] Question: Trends in performance by vertical and same-store sales commentary - Travel and payments performed well, while ticket sales showed some softness, particularly in June, with expectations for a challenging comparison to the previous year's strong performance [39][41] Question: Management of operating expenses - Operating expenses were managed well, with expectations for similar levels in the second half of the year [43][45] Question: Adoption trends for adaptive checkout and its impact on new logos - Adaptive checkout has seen double-digit percentage adoption, contributing positively to the overall value proposition [47][49] Question: Proportion of fraud from large coordinated attacks - There has been an increase in professional, coordinated fraud attacks, primarily through remote desktop hacking and data breaches [72] Question: Renewal rates and upsell strategies - The company achieved a 100% renewal success rate and continues to focus on creating unmatched value for merchants [80][81]

Financial Data and Key Metrics Changes - The company reported revenue of $7.4 million for Q2 2025, marking a 31% increase year over year [31] - Adjusted EBITDA for Q2 was negative $2.5 million, an improvement from negative $3.1 million in Q2 2024 [32] - Gross margin on IFRS basis was approximately 67%, up from 65% in Q2 last year [32] Business Line Data and Key Metrics Changes - Platform revenue reached $2.5 million, up 23% year over year, marking the fourth consecutive quarter of growth exceeding 20% [31] - Solutions revenue increased by 36% year over year to $4.9 million, reflecting proactive expansion of product capabilities [31][24] Market Data and Key Metrics Changes - The air cargo market saw a 3% increase in volumes compared to Q2 last year, despite challenges from tariff changes [14] - Ocean freight rates rose 43% from Q1 but were still 11% lower than last year, indicating capacity growth and potential overcapacity [15] Company Strategy and Development Direction - The company aims to digitalize international freight, positioning itself as a leading global freight platform [10][11] - Strategic expansion includes adding new carriers, with a total of 75 carriers now on the platform, enhancing coverage on critical routes [19] - The company is focused on increasing liquidity in ocean capacity and modernizing IT among ocean carriers [21][23] Management's Comments on Operating Environment and Future Outlook - Management noted that while tariffs have created some headwinds, the overall impact is minor compared to the trend of digitalization driving long-term growth [17] - The company remains on track to achieve breakeven adjusted EBITDA by the end of 2026, with confidence in sustaining growth rates [33][75] Other Important Information - The company has a strong balance sheet with $34 million in cash and cash equivalents [33] - The company plans to participate in several investor events, including the H. C. Wainwright Annual Investment Conference in September [4] Q&A Session Summary Question: Why did the company raise full year GBV guidance but keep revenue largely unchanged? - Management indicated that the mix of transactions affects revenue, with some lower take rate transactions growing faster [38][39] Question: How is the ShipStar position helping drive solutions revenue? - The integration of ShipStar has enhanced the product portfolio, enabling cross-sell opportunities and improving data offerings [41][42] Question: What is driving the pressure for modernization in the ocean freight sector? - The need for digital connections is being driven by customer demand for efficiency, moving away from traditional methods like Excel sheets [52] Question: Are there any strategic changes or new growth areas being evaluated? - Management is continuously reviewing resource allocation but does not expect any major changes at this time [60][61] Question: How much did FX fluctuations impact Q2 profitability? - FX fluctuations significantly affected adjusted EBITDA, but the company has managed to hedge nearly 100% of its exposure [62][64] Question: How does the company expect to achieve breakeven by the end of next year? - Management is confident in reaching breakeven with current growth trends and operational expense management [75][76]

Financial Data and Key Metrics Changes - The company reported a revenue of RMB950 million for the first half of 2025, with over RMB300 million coming from commercialized drugs, marking a significant achievement in its first year of commercialization [50][51] - Gross profit was RMB660 million, comparable to the previous year, while the net loss for the first half was RMB145 million, with an adjusted loss of RMB69 million after one-off budget adjustments [52][53] Business Line Data and Key Metrics Changes - The company has three main products ready for the market, with significant progress in approvals and commercialization efforts [12][21] - The commercialization team has expanded to nearly 400 personnel to support the increasing number of products [12] Market Data and Key Metrics Changes - The company has covered over 30 provinces, 300 cities, and over 1,000 hospitals across China, with partnerships established with over 400 pharmacies [28][32] - The company is actively working towards gaining medical insurance coverage for its products, which is expected to enhance market access [33][34] Company Strategy and Development Direction - The company aims to advance differentiated pipelines targeting significant medical needs, optimizing payload linker strategies, and exploring applications in non-oncology areas [26] - The focus is on expanding global partnerships and strengthening strategic collaborations to maximize the value of its pipelines [26] Management Comments on Operating Environment and Future Outlook - Management expressed optimism about the future income from sales revenue, anticipating continued cash flow generation from both R&D partnerships and commercialized drugs [51] - The company is preparing for the implementation of new medical insurance policies, which could significantly impact product sales strategies [97][100] Other Important Information - The company completed a follow-on financing of US$250 million and is included in several global equity indexes, enhancing its financial stability [25] - The company is involved in ongoing litigation regarding IP disputes with several founders, which has been accepted for review by the Sichuan Provincial High Court [101] Q&A Session Summary Question: What is the breakdown of sales revenue for breast cancer and lung cancer? - Lung cancer is the biggest contributor to sales revenue, consistent with patient numbers and indications. The sales expenses are expected to decrease once products are included in medical insurance coverage [62][63] Question: What is the focus for R&D going into the next stage? - The focus is on developing differentiated products targeting clinical demands, with an emphasis on bispecific targets and new payload strategies [68][70] Question: Can you provide guidelines on the sales trend for Q3? - The company expects quarter-over-quarter growth, with significant contributions anticipated from lung cancer indications [72] Question: What is the rationale behind the clinical trial design for PD L1 positive and negative patients? - The company is focusing on first-line treatment for wild-type non-small cell lung cancer, with ongoing projects in development [88] Question: How is the company planning to navigate the new medical insurance policy? - The company is prioritizing entry into the medical insurance catalog and is actively preparing to comply with the new policy [97][98]

Financial Data and Key Metrics Changes - Total revenue for Q2 2025 was $155.6 million, up 122% sequentially from Q1 and up 57% year over year [8][20] - Gross profit was $12.8 million, with an adjusted EBITDA of $17.3 million, showing significant improvement from Q1 [8][27] - Self mining revenue reached $59.3 million, a 42.5% increase year over year and a 59.4% increase sequentially [21] - Total operating expenses were $42.3 million, up from $26.1 million in Q2 2024, primarily due to R&D costs [25] Business Line Data and Key Metrics Changes - Self mining hash rate increased by 103.3% year over year and 45.5% sequentially, contributing to revenue growth [21] - Sales revenue from SealMiner ASICs was $69.5 million, compared to $0 in Q2 2024 [21] - Cloud Hash Rate revenue declined to $0, down from $12.2 million in Q2 2024, due to the expiration of long-term contracts [22] Market Data and Key Metrics Changes - The average operating hash rate increased by 46% to 14.2 exahash in Q2 from 9.7 exahash in Q1 [8] - The self mining hash rate further grew to 22.3 exahash as of July 2025, representing a 162% increase from the beginning of the year [9] Company Strategy and Development Direction - The company is focused on a vertically integrated and technology-driven growth strategy, investing in chip design, supply chain, and manufacturing [9][10] - Plans to achieve a self mining hash rate of 40 exahash by October 2025, with expectations to exceed this target by year-end [10][18] - The company is also developing the CLO4 chip, targeting breakthrough efficiency for Bitcoin mining and other high-performance applications [13][14] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, citing strong momentum and a solid foundation for growth [9][11] - The company anticipates record results on a run rate basis by the end of the year, setting a strong foundation for 2026 and beyond [11][19] - Management highlighted the importance of energy efficiency and performance leadership in the competitive landscape [11][12] Other Important Information - The company has energized 361 MW of data center capacity for self mining as of July 2025, with plans to increase total available power capacity to nearly 1.6 GW [15][16] - The company is in advanced negotiations for a development partner for its HPC AI initiative in Clarington, Ohio [17][18] Q&A Session Summary Question: What is the risk around construction at the Clarington site? - Management indicated that capital requirements would be minimal and provided through the partner, with construction loans on top [34] Question: How is the demand for ASIC production evolving? - Management noted increased demand due to rising hash prices and Bitcoin prices, contributing to a stronger market [36] Question: What is the current status of the HPC initiative? - The focus is on a build-to-suit approach, with flexibility depending on the final customer for the site [41] Question: What is the balance between self mining and external sales for SealMiners? - The company prioritizes internal use for self mining due to high margins, with a gradual transition to external sales as internal capacity fills up [52] Question: What is the outlook for ASIC prices based on current market dynamics? - Management stated that pricing for the A3 chip will be competitive, with significant efficiency advantages [48] Question: What is the customer composition for SealMiner sales? - The sales have been a mix of both public and private miners, with a focus on distributing units for market feedback [109]

Financial Data and Key Metrics Changes - The company reported a revenue of RMB 950 million for the first half of 2025, with over RMB 300 million coming from commercialized drugs, marking a significant achievement in its first year of commercialization [52][53]. - The gross profit was RMB 660 million, comparable to the previous year, while the net loss for the first half was RMB 145 million, with an adjusted loss of RMB 69 million after one-off budget adjustments [54][55]. - Cash and financial assets totaled RMB 4.5 billion, indicating a healthy financial status to support upcoming R&D and innovation [58]. Business Line Data and Key Metrics Changes - The company has three main products ready for the market, with significant progress in commercialization, covering over 30 provinces and 300 cities, and engaging over 10,000 doctors [32][34]. - The commercialization team has expanded to nearly 400 personnel to support the increasing number of products ready for market [14][15]. Market Data and Key Metrics Changes - The company has successfully partnered with over 400 pharmacies across China, enhancing its market access and professional services [32][34]. - The company is actively pursuing medical insurance coverage for its products, with seven provinces already covered under specific affordable care programs [36][37]. Company Strategy and Development Direction - The company aims to advance differentiated pipelines targeting significant medical needs, optimizing payload linker strategies, and exploring applications in non-oncology areas [30]. - The focus is on developing ADCs and small molecules, with an emphasis on bi-specific targets and innovative payloads to replace traditional chemotherapy [70][72]. Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future income from sales revenue, anticipating continued cash flow generation from both R&D partnerships and commercialized drugs [53]. - The company is preparing for the implementation of new medical insurance policies, which are expected to enhance market access and sales volume [100][101]. Other Important Information - The company has completed a follow-on financing of USD 250 million and is included in major global equity indexes, enhancing its market presence [29]. - The company has made significant advancements in clinical trials, with multiple pivotal trials initiated both domestically and globally [25][26]. Q&A Session Summary Question: What is the breakdown of sales revenue for breast cancer and lung cancer? - Lung cancer is the biggest contributor to sales revenue, consistent with patient numbers and indications. The sales expenses are expected to decrease once products are included in the national medical insurance catalog [60][64]. Question: What is the focus for R&D going into the next stage? - The focus is on developing differentiated products targeting clinical demands, with an emphasis on bi-specific targets and innovative payloads [70][72]. Question: Can you provide guidelines on the sales trend for Q3? - The company has recorded quarter-over-quarter growth of several dozen percentage points, indicating a positive sales trend [76]. Question: What is the rationale behind the clinical trial design for PD L1 positive and negative patients? - The company is focusing on developing effective treatments for both PD L1 positive and negative patients, with ongoing trials to assess efficacy [91]. Question: How does the company plan to navigate the new medical insurance policies? - The company is prioritizing entry into the medical insurance catalog and is actively preparing to comply with new policies to enhance market access [100][101].

Financial Data and Key Metrics Changes - Total revenue for Q2 2025 was $155.6 million, up 122% sequentially from Q1 and up 57% year over year [6][18] - Gross profit was $12.8 million, with adjusted EBITDA at $17.3 million, showing significant improvement from Q1 [6][24] - Self mining revenue reached $59.3 million, a 42.5% increase year over year and a 59.4% increase sequentially [19] - Adjusted profit was negative $24.4 million, compared to positive $3.2 million in Q2 2024 [24] Business Line Data and Key Metrics Changes - Self mining hash rate increased by 103.3% year over year and 45.5% sequentially, contributing to revenue growth [19] - SealMiner sales revenue was $69.5 million, compared to $0 in Q2 2024 and $4.1 million in Q1 2025 [19] - Cloud Hash Rate revenue declined to $0 from $12.2 million in Q2 2024 due to the expiration of long-term contracts [20] Market Data and Key Metrics Changes - The average operating hash rate increased by 46% to 14.2 exahash in Q2 from 9.7 exahash in Q1 [6] - As of July 2025, self mining hash rate further grew to 22.3 exahash, representing a 162% increase from the beginning of the year [7] Company Strategy and Development Direction - The company is focused on a vertically integrated and technology-driven growth strategy, investing in chip design, supply chain, and manufacturing [7][10] - Plans to achieve a self mining hash rate of 40 exahash by October 2025, with expectations to exceed this target by year-end [9][16] - The company is developing the CLO4 chip with two independent designs to ensure success and improve energy efficiency [12][13] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, citing strong momentum and a positive outlook for the remainder of 2025 and beyond [7][17] - The company anticipates record results on a run rate basis by the end of the year, setting a strong foundation for 2026 [10][17] Other Important Information - The company has energized 361 MW of data center capacity for self mining, with plans to increase total available power capacity to nearly 1.6 GW [14][15] - The company ended the quarter with $299.8 million in cash and cash equivalents, indicating a strong financial position [27][28] Q&A Session Summary Question: What is the risk around construction at the Clarington site? - Management indicated that capital requirements would be minimal and provided through a partner, with construction loans on top [33] Question: How is the pricing for SealMiner sales? - Pricing remained consistent with the previous quarter, with increased demand due to rising Bitcoin prices [35][85] Question: What is the current status of the HPC initiative in Clarington? - The focus is on a build-to-suit approach, with flexibility depending on the final customer [40] Question: What is the demand environment for ASICs? - Demand has remained strong, with no signs of decline, and the market has picked up significantly [71] Question: How will the company balance self mining versus external sales of SealMiners? - The company prioritizes internal use due to high margins but plans to transition to external sales as internal capacity fills up [51]

Financial Data and Key Metrics Changes - Consolidated revenue for Q2 2025 increased by $13.6 million to $60.4 million compared to Q2 2024, driven by stronger movie releases [30] - Global operating income for Q2 2025 was $2.9 million, a 138% increase from a loss of $7.7 million in Q2 2024 [6] - Positive EBITDA for Q2 2025 was $6.3 million, up over 276% from a negative EBITDA of $3.6 million in Q2 2024 [7][36] - Net loss attributable to Reading International for Q2 2025 decreased by $10.1 million to a loss of $2.7 million compared to a loss of $12.8 million in Q2 2024 [32] Business Line Data and Key Metrics Changes - Global cinema revenue for Q2 2025 was $56.8 million, a 32% increase from Q2 2024, representing over 79% of pre-pandemic levels [7] - Global cinema operating income for Q2 2025 increased by 218% to $5.5 million, marking the best performance since 2019 [8] - Global real estate revenues for Q2 2025 decreased slightly to $4.7 million from $5 million in Q2 2024, while operating income increased by 56% to $1.5 million [8][20] Market Data and Key Metrics Changes - Approximately 47% of total revenue was generated in Australia and New Zealand, with a 2.7% and 1.9% weakening of the Australian and New Zealand dollar against the U.S. dollar, respectively [9] - U.S. cinema revenues increased by 41% to $30.3 million compared to Q2 2024, with operating income improving by 152% to $2.3 million [18] - Australian cinema revenue increased by 24% to $22.9 million, while New Zealand cinema revenue also increased by 24% to $3.6 million [19] Company Strategy and Development Direction - The company is focused on reducing overall debt, having repaid over $102.5 million since June 2020 [5] - Strategic initiatives include enhancing food and beverage programs, with record spending per patron in Australia, New Zealand, and the U.S. [13][15] - The company is working with landlords to recalibrate occupancy costs to reflect current economic realities [17] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the theatrical experience, citing strong performance from recent movie releases [10] - Anticipation for a slower third quarter but high hopes for a strong fourth quarter with an exciting film slate [11][12] - The company believes it is well-positioned for stronger growth in 2026 and beyond, supported by favorable interest rates and a stable lineup of Hollywood releases [28] Other Important Information - The company completed the sale of its Cannon Park assets for AUD 32 million, using proceeds to pay off debts [5] - The average ticket price in the U.S. reached $13.44, the highest second quarter figure ever [18] - The company is implementing new loyalty programs to drive customer engagement and revenue [16] Q&A Session Summary Question: Why was Rotorua land and improvements removed from held for sale? - The asset was initially classified for sale but failed to attract interest during a challenging period, and it continues to generate reasonable cash flow [42] Question: What is NAB's appetite for longer-dated facility? - The company is working with NAB on a longer-term extension, emphasizing a good working relationship [43] Question: What are the landlord's seismic upgrade timeline commitments? - The new owner is advancing plans for seismic upgrades, expected to be completed in 2026, with significant renovations planned for the cinema [45][46] Question: Will there be an investor relations day? - Currently, there is no investor relations day scheduled, but management is evaluating future opportunities for engagement [47]

Financial Data and Key Metrics Changes - As of June 30, 2025, the company reported net revenue of $40.52 million, down 15% from $47.79 million in the same period of 2024, primarily due to a sharp reduction in sales to customers in the residential energy storage market [8][9][13] - The company reported net losses attributable to shareholders of $3.07 million and total net losses of $3.36 million, with the battery segment accounting for $2.07 million in net losses [13] Business Line Data and Key Metrics Changes - The battery segment experienced a significant decline in sales, particularly in the residential energy storage market, where sales fell by 44.8% year over year [8][9] - The raw materials production unit, Heitrans, reported net revenues of approximately $19.43 million, up 59.36% from $12.19 million in the same period of 2024, with net losses narrowing by 32.02% [13][14] Market Data and Key Metrics Changes - The company is facing supply constraints in its Nanjing facility due to surging demand for its model 32140 cells, with phase two of the Nanjing plant delayed until Q4 [7][8] - The company is targeting high-quality European and American customers while expanding its market share in India and the portable power supply industry [9][10] Company Strategy and Development Direction - The company is transitioning from a small format battery model to a larger, more advanced model (model 4135) to meet market demand and reduce costs [6][10] - Establishing battery cell production capacity in the US remains a core element of the company's long-term strategy, although the Malayan project has been temporarily paused [10][11] Management's Comments on Operating Environment and Future Outlook - Management anticipates a strong recovery in consolidated results by year-end, driven by the completion of product upgrades and the expansion of the Nanjing facility [8][14] - The company believes that the financial performance of both Heitrans and the battery segment will see a strong rebound in the near future [14][15] Other Important Information - The company has spent approximately $1.3 to $1.5 million on its stock buyback program, which is a one-year long initiative [30] Q&A Session Summary Question: Competitive landscape and pricing pressures - Management noted that battery technology is rapidly developing, and the market is sensitive to costs, leading to a transition to larger battery cells to reduce costs [17][21] Question: Development status of the 46 series cells - The company has been researching the 46 series for over two years and aims to achieve mass production by the end of next year, contingent on securing significant orders [24][26] Question: Factors causing delays in the Nanjing expansion - The delay was primarily due to issues with equipment suppliers, but management expects to resolve these problems soon and complete the expansion by the end of the year [27][29] Question: Stock buyback activity - The company has been active in its stock buyback program, spending approximately $1.3 to $1.5 million so far [30]

Tongcheng Travel Holdings (00780) Q2 2025 Earnings Call August 18, 2025 07:30 AM ET Company ParticipantsKylie Yeung - Director - IRJoyce Li - VP & Head - Capital MarketsFan Lei - CFOBrian Gong - Internet & Media ResearchYang Liu - Executive DirectorThomas Chong - Managing DirectorConference Call ParticipantsWei Xiong - Equity Research AnalystJia Wei Lee - Summer AnalystOperatorGood day, and thank you for standing by. Welcome to Tongcheng Travel twenty twenty five Second Quarter and Interim Results Announcem ...

Financial Data and Key Metrics Changes - The company reported a net revenue of RMB4.7 billion, marking a 10% year-over-year increase from the same period in 2024 [26] - Adjusted net profit rose to RMB775 million, reflecting an 18% year-over-year growth, with adjusted net margin expanding to 16.6% compared to 15.5% in the same period last year [26] - Gross profit increased by 10.6% year-over-year to RMB3.0 billion, with gross margin rising slightly to 65% [29] - Adjusted EBITDA increased by 29.7% to RMB1.2 billion, with a 25.4% margin compared to a 21.5% margin in the same period last year [30] Business Line Data and Key Metrics Changes - The accommodation reservation business achieved RMB1.4 billion, representing a 15.2% increase from the same period in 2024 [27] - Transportation ticketing revenue reached RMB1.9 billion, marking a 7.9% year-over-year increase [28] - The hotel management business sustained healthy expansion, with over 2,700 hotels in operation and nearly 1,500 in the pipeline [16] Market Data and Key Metrics Changes - The international air ticketing volume reached a historical high, delivering nearly 30% year-over-year growth [14] - The cumulative number of passengers served on the platform reached 2 billion, suggesting a stable user purchase frequency of 8 times per year [20] - The twelve-month annual paying users climbed to over 250 million, representing a 10% year-over-year increase [20] Company Strategy and Development Direction - The company is focused on expanding its core OTA business while enhancing its brand awareness and market share [34] - There is a commitment to leveraging technology, including AI, to drive growth and improve user experience [21][23] - The company aims to deepen its presence in the hotel management sector, targeting over 3,000 hotels in operation by the end of 2025 [73] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of the Chinese travel market, anticipating steady year-over-year growth in both top line and bottom line [33] - The shift in consumer preferences towards experiential travel is seen as a significant opportunity for growth [56] - The company plans to maintain a disciplined approach to sales and marketing spending to ensure optimal returns [56] Other Important Information - The company announced the acquisition of a 100% stake in Wanda Hotel Management, which is expected to diversify brand metrics and strengthen market presence [17] - The balance of cash, cash equivalents, restricted cash, and short-term investments was RMB13.5 billion as of June 30, 2025 [32] Q&A Session Summary Question: Can management provide more color regarding the volume growth, ADR, and take rate in the accommodation business? - Management noted that the domestic ADR has stabilized year-over-year and is expected to continue growing, driven by a shift in user behavior towards higher quality products [41][43] Question: How does the company balance strategic resource allocation between core OTA and pursuing a diverse business portfolio? - Management emphasized that the OTA business remains the foundation and strategic focus, while also pursuing organic growth opportunities and selective M&A [46][48] Question: What are the reasons for the low growth in domestic airline ticketing volume? - Management indicated that the industry has returned to a normalized growth trajectory after two exceptional years, but expects the OTA business to outpace overall market growth [52][54] Question: Can management share more details on outbound travel performance? - Management reported significant growth in international air ticketing and accommodation volumes, with a focus on improving marketing efficiency and ROI [58][59] Question: How does management view the impact of JV and BaBa's investments in the OTA market? - Management believes that the competitive landscape remains stable, as new entrants face challenges in replicating established relationships and operational efficiencies [64][66] Question: What is the expected margin outlook for the OTA business? - Management expects steady year-over-year improvement in margins, driven by reduced sales and marketing expenses and improved operational efficiency [69][70] Question: What is the latest development plan for the hotel management business? - Management aims to operate over 3,000 hotels by the end of 2025, with a focus on enhancing quality and brand recognition [73][74] Question: Can management comment on the standalone app's user base and revenue contribution? - Management reported that the app accounted for over 8% of core OTA revenue in Q2, with ongoing efforts to grow the user base and engagement [82] Question: How is AI evolving within the company? - Management highlighted the integration of AI into the travel planning process, improving operational efficiency and user experience [85][86]